On May 23, 2026, CoreWeave (CRWV) insider Jeff Baker sold 1,320 shares of stock, as reported by DailyPolitical source...
On May 23, 2026, CoreWeave (CRWV) insider Jeff Baker sold 1,320 shares of stock, as reported by DailyPolitical source 5. While the sale amount is modest, insider transactions can be a signal of sentiment. This is a single small transaction, so confidence is low. No other insider transactions were reported. The sale aligns with a cautious view on CRWV, despite recent bullish articles from Motley Fool and Aschenbrenner source 2, source 7. The signal is weak but relevant as a potential insider sentiment indicator.
CRWV has not made a large direction-matching 30-90 day move yet.
signal brief
On May 23, 2026, CoreWeave (CRWV) insider Jeff Baker sold 1,320 shares of stock, as reported by DailyPolitical source 5. While the sale amount is modest, insider transactions can be a signal of sentiment. This is a single small transaction, so confidence is low. No other insider transactions were reported. The sale aligns with a cautious view on CRWV, despite recent bullish articles from Motley Fool and Aschenbrenner source 2, source 7. The signal is weak but relevant as a potential insider sentiment indicator.
evidence
- https://investors.coreweave.comweb
- https://www.fool.com/investing/2026/05/23/hypergrowth-ai-stocks-buy-hold-decade-crwv-nbis/?source=iedfolrf0000001web
- https://finance.yahoo.com/sectors/technology/articles/2-hypergrowth-ai-stocks-buy-193400155.htmlweb
- https://247wallst.com/investing/2026/05/23/ulty-paid-68-7-in-distributions-while-its-stock-price-fell-47/web
- https://www.dailypolitical.com/2026/05/23/coreweave-nasdaqcrwv-insider-jeff-baker-sells-1320-shares-of-stock.htmlweb
- https://www.insidermonkey.com/blog/jefferies-sees-core-scientific-corz-well-positioned-for-ai-infrastructure-demand-growth-1767806/web
- https://www.insidermonkey.com/blog/coreweave-crwv-top-10-aschenbrenner-stocks-to-buy-1767816/web
- https://fortune.com/2026/05/23/what-business-is-space-x-in-ipo-filing-stock/web
Decision support, not stock advice. This signal is research with cited evidence — not a recommendation to buy, sell, or hold any security.